Annual Report

Adaptive Biotechnologies Corp Filed 2020-02-26 Acc 0001564590-20-006830

Documents 1

2021-02-24 10-K Annual Report
2020-02-26 10-K Annual Report
2020-02-26 8-K Results of operations
2020-02-24 4 President sold 85,000 shares at an average $33.57 ($2,853,294)
2020-02-24 4 Chief Scientific Officer sold 7,400 shares at an average $33.46 ($247,578)
2020-02-20 4 Chief Scientific Officer sold 25,900 shares at an average $31.76 ($822,679)
2020-02-20 4 President sold 80,000 shares at $33.00 ($2,640,000)

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading adpt-10k_20191231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…